The antigenic evolution of influenza: Drift or thrift?

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 368, Issue 1614, 2013, Pages

  Wikramaratna, Paul S ^a   Sandeman, Michi ^a   Recker, Mario ^a   Gupta, Sunetra ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Epidemiology; Epitope; Influenza

Indexed keywords

ANTIBODY; ANTIGEN; EPIDEMIOLOGY; INFLUENZA; VACCINE; VIRUS;

EPITOPE; INFLUENZA VACCINE;

ANTIGEN ANTIBODY REACTION; ARTICLE; BIOLOGICAL MODEL; GENETICS; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A; MOLECULAR EVOLUTION;

ANTIGEN-ANTIBODY REACTIONS; EPITOPES; EVOLUTION, MOLECULAR; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MODELS, IMMUNOLOGICAL;

MLCS; MLOWN;

EID: 84880449077     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2012.0200     Document Type: Article

References (74)

1. Gomes MGM, Medley GF, Nokes DJ. 2002 On the determinants of population structure in antigenically diverse pathogens. Proc. R. Soc. Lond. B 269, 227-233. (doi:10.1098/rspb.2001.1869)
2. Gog JR, Grenfell BT. 2002 Dynamics and selection of many-strain pathogens. Proc. Natl Acad. Sci. USA 99, 17 209-17 214. (doi:10.1073/pnas.252512799)
3. Koelle K, Cobey S, Grenfell BT, Pascual M. 2006 Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science 314, 1898-1903. (doi:10.1126/science.1132745)
4. Bedford T, Rambaut A, Pascual M. 2012 Canalization of the evolutionary trajectory of the human influenza virus. BMC Biol. 10, 38. (doi:10.1186/ 1741-7007-10-38)
5. Ferguson NM, Galvani AP, Bush RM. 2003 Ecological and immunological determinants of influenza evolution. Nature 422, 428-433. (doi:10.1038/ nature01509)
6. Recker M, Pybus OG, Nee S, Gupta S. 2007 The generation of influenza outbreaks by a network of host immune responses against a limited set of antigenic types. Proc. Natl Acad. Sci. USA 104, 7711-7716. (doi:10.1073/pnas.0702154104)
7. Gray RR, Pybus OG, Salemi M. 2011 Measuring the temporal structure in serially sampled phylogenies. Methods Ecol. Evol. 2, 437-445. (doi:10.1111/j. 2041-210X.2011.00102.x)
8. Gupta S, Maiden MC, Feavers IM, Nee S, May RM, Anderson RM. 1996 The maintenance of strain structure in populations of recombining infectious agents. Nat. Med. 2, 437-442. (doi:10.1038/ nm0496-437)
9. Buckee CO, Recker M, Watkins ER, Gupta S. 2011 Role of stochastic processes in maintaining discrete strain structure in antigenically diverse pathogen populations. Proc. Natl Acad. Sci. USA 108, 15 504-15 509. (doi:10.1073/pnas.1102445108)
10. Gupta S, Ferguson N, Anderson R. 1998 Chaos, persistence, and evolution of strain structure in antigenically diverse infectious agents. Science 280, 912-915. (doi:10.1126/science.280.5365.912)
11. Hirst GK. 1941 The agglutination of red cells by allantoic fluid of chick embryos infected with influenza virus. Science 94, 22-23. (doi:10.1126/ science.94.2427.22)
12. Smith DJ, Lapedes AS, De Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2004 Mapping the antigenic and genetic evolution of influenza virus. Science 305, 371-376. (doi:10.1126/science.1097211)
13. Plotkin JB, Dushoff J, Levin SA. 2002 Hemagglutinin sequence clusters and the antigenic evolution of influenza A virus. Proc. Natl Acad. Sci. USA 99, 6263-6268. (doi:10.1073/pnas.082110799)
14. Johansson BE, Kilbourne ED. 1992 Influenza vaccine strain selection: equivalence of two antigenically distinct haemagglutinin variants of 1989 H3N2 influenza A virus in protection of mice. Vaccine 10, 603-606. (doi:10.1016/0264-410X(92)90440-U)
15. Gillim-Ross L, Santos C, Chen Z, Aspelund A, Yang CF, Ye D, Jin H, Kemble G, Subbarao K. 2008 Avian influenza H6 viruses productively infect and cause illness in mice and ferrets. J. Virol. 82, 10 854-10 863. (doi:10.1128/JVI.01206-08)
16. Wood JM, Major D, Heath A, Newman RW, Hoschler K, Stephenson I, Clark T, Katz JM, Zambon MC. 2012 Reproducibility of serology assays for pandemic influenza H1N1: collaborative study to evaluate a candidate WHO International Standard. Vaccine 30, 210-217. (doi:10.1016/j. vaccine.2011.11.019)
17. Yoden S, Kida H, Yanagawa R. 1982 An avian influenza virus of which infectivity is neutralized by antisera lacking hemagglutination-inhibition activity: brief report. Arch. Virol. 74, 205-210. (doi:10.1007/BF01314713)
18. Rowe T, Abernathy RA, Hu-Primmer J, Thompson WW, Lu X, Lim W, Fukuda K, Cox NJ, Katz JM. 1999 Detection of antibody to avian influenza a (H5N1) virus in human serum by using a combination of serologic assays. J. Clin. Microbiol. 37, 937.
19. Leuwerke B, Kitikoon P, Evans R, Thacker E. 2008 Comparison of three serological assays to determine the cross-reactivity of antibodies from eight genetically diverse U.S. swine influenza viruses. J. Vet. Diagn. Invest. 20, 426-432. (doi:10.1177/104063870802000403)
20. Gitelman AK, Kaverin NV, Kharitonenkov IG. 1986 Dissociation of the haemagglutination inhibition and the infectivity neutralization in the reactions of influenza A/USSR/90/77 (H1N1) virus variants with monoclonal antibodies. J. Gen. Virol. 67, 2247-2251. (doi:10.1099/0022-1317-67-10-2247)
21. Kida H, Brown LE, Webster RG. 1982 Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1/80 (H7N7) influenza virus. Virology 122, 38. (doi:10.1016/ 0042-6822(82)90375-0)
22. Katz JM, Hancock K, Xu X. 2011 Serologic assays for influenza surveillance, diagnosis and vaccine evaluation. Expert Rev. Anti Infect. Ther. 9, 669-683. (doi:10.1586/eri.11.51)
23. Yewdell JW. 2011 Viva la revolution: rethinking influenza a virus antigenic drift. Curr. Opin. Virol. 1, 177-183. (doi:10.1016/j.coviro.2011.05.005)
24. Wang TT, Tan GS, Hai R, Pica N, Petersen E, Moran TM, Palese P. 2010 Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. PLoS Pathog. 6, e1000796. (doi:10.1371/journal.ppat.1000796)
25. Sui J et al. 2009 Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16, 265-273. (doi:10.1038/nsmb.1566)
26. Okuno Y, Isegawa Y, Sasao F, Ueda S. 1993 A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J. Virol. 67, 2552-2558.
27. Sandbulte MR et al. 2011 Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses. Proc. Natl Acad. Sci. USA 108, 20 748-20 753. (doi:10.1073/pnas.1113801108)
28. Hancock K et al. 2009 Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 361, 1945-1952. (doi:10.1056/NEJMoa0906453)
29. Itoh Y et al. 2009 In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460, 1021-1025.
30. Bandaranayake D et al. 2010 Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS ONE 5, e13211. (doi:10.1371/journal.pone.0013211)
31. Chi CY, Liu CC, Lin CC, Wang HC, Cheng YT, Chang CM, Wang J-R. 2010 Preexisting antibody response against 2009 pandemic influenza H1N1 viruses in the Taiwanese population. Clin. Vaccine Immunol. 17, 1958-1962. (doi:10.1128/CVI.00212-10)
32. Gilbert GL, Cretikos MA, Hueston L, Doukas G, O'Toole B, Dwyer DE. 2010 Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter. PLoS ONE 5, e122562. (doi:10.1371/journal.pone.0012562
33. Ikonen N, Strengell M, Kinnunen L, Osterlund P, Pirhonen J, Broman M, Davidkin I, Zeigler T, Julkunen I. 2010 High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill. 15, 19478.
34. Mak GC, Choy PW, Lee WY, Wong AH, Ng KC, Lim W. 2010 Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong. J. Med. Virol. 82, 1809-1815. (doi:10.1002/ jmv.21895)
35. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. 2010 Incidence of 2009 pandemic influenza A H1N1 infection in England: a crosssectional serological study. Lancet 375, 1100-1108. (doi:10.1016/S0140-6736(09)62126-7)
36. New South Wales Public Health Network. 2009 Progression and impact of the first winter wave of the 2009 pandemic H1N1 influenza in New South Wales, Australia. Euro Surveill. 14, 19365.
37. Karageorgopoulos DE, Vouloumanou EK, Korbila IP, Kapaskelis A, Falagas ME. 2011 Age distribution of cases of 2009 (H1N1) pandemic influenza in comparison with seasonal influenza. PLoS ONE 6, e21690. (doi:10.1371/journal.pone.0021690)
38. Kash JC, Qi L, Dugan VG, Jagger BW, Hrabal RJ, Memoli MJ, Morens DM, Taubenberger JK. 2010 Prior infection with classical swine H1N1 influenza viruses is associated with protective immunity to the 2009 pandemic H1N1 virus. Influenza Other Respir. Viruses 4, 121-127. (doi:10.1111/j.1750-2659.2010.00132.x)
39. Manicassamy B, Medina RA, Hai R, Tsibane T, Stertz S, Nistal-Villán E, Palese P, Basler CF, García-Sastre A. 2010 Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog. 6, e1000745. (doi:10.1371/ journal.ppat.1000745)
40. Min JY, Chen GL, Santos C, Lamirande EW, Matsuoka Y, Subbarao K. 2010 Classical swine H1N1 influenza viruses confer cross protection from swine-origin 2009 pandemic H1N1 influenza virus infection in mice and ferrets. Virology 408, 128-133. (doi:10.1016/j.virol.2010.09.009)
41. O'Donnell CD, Wright A, Vogel L, Wei CJ, Nabel GJ, Subbarao K. 2012 The effect of priming with H1N1 influenza viruses of variable antigenic distance on challenge with 2009 pandemic H1N1 virus. J. Virol. 86, 8625-8633. (doi:10.1128/JVI.00147-12)
42. McCullers JA, Van De Velde LA, Allison KJ, Branum KC, Webby RJ, Flynn PM. 2010 Recipients of vaccine against the 1976 'swine flu' have enhanced neutralization responses to the 2009 novel H1N1 influenza virus. Clin. Infect. Dis. 50, 1487-1492. (doi:10.1086/652441)
43. Skountzou I et al. 2011 Immunity to Pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus. J. Immunol. 185, 1642-1649. (doi:10.4049/ jimmunol.1000091)
44. Wikramaratna PS, Gupta S. 2009 Influenza outbreaks. J. Cell. Microbiol. 11, 1016-1024. (doi:10.1111/j.1462-5822.2009.01320.x)
45. Tsuchiya E, Sugawara K, Hongo S, Matsuzaki Y, Muraki Y, Li ZN, Nakamura K. 2001 Antigenic structure of the haemagglutinin of human influenza A/H2N2 virus. J. Gen. Virol. 82, 2475-2484.
46. Vincent AL, Lager KM, Ma W, Lekcharoensuk P, Gramer MR, Loiacono C, Richt JA. 2006 Evaluation of hemagglutinin subtype 1 swine influenza viruses from the United States. Vet. Microbiol. 118, 212-222. (doi:10.1016/j.vetmic.2006.07.017)
47. Chen H et al. 2006 Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc. Natl Acad. Sci. USA 103, 2845-2850. (doi:10.1073/pnas.0511120103)
48. Coudeville L, Bailleux F, Riche B, Megas F, Andre P, Ecochard R. 2010 Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a Bayesian random-effects model. BMC Med. Res. Methodol. 10, 18. (doi:10.1186/1471-2288-10-18)
49. Osterholm MT, Kelley NS, Sommer A, Belongia EA. 2012 Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect. Dis. 12, 36-44. (doi:10.1016/S1473-3099(11)70295-X)
50. Beare AS, Hobson D, Reed SE, Tyrrell DA. 1968 A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on influenza and other respiratory virus vaccines. Lancet 2, 418-422. (doi:10.1016/S0140-6736(68)90463-7)
51. Sato K, Morishita T, Nobusawa E, Tonegawa K, Sakae K, Nakajima S, Nakajima K. 2004 Amino-acid change on the antigenic region B1 of H3 haemagglutinin may be a trigger for the emergence of drift strain of influenza A virus. Epidemiol. Infect. 132, 399-406. (doi:10.1017/S0950268803001821)
52. Lillie PJ et al. 2012 Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVANP + M1, in humans. Clin. Infect. Dis. 55, 19-25. (doi:10.1093/cid/cis327)
53. Wiley DC, Wilson IA, Skehel JJ. 1981 Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289, 373-378. (doi:10.1038/289373a0)
54. Gupta V, Earl DJ, Deem MW. 2006 Quantifying influenza vaccine efficacy and antigenic distance. Vaccine 24, 3881-3888. (doi:10.1016/j.vaccine.2006.01.010)
55. Pan K, Subieta KC, Deem MW. 2011 A novel sequence-based antigenic distance measure for H1N1, with application to vaccine effectiveness and the selection of vaccine strains. Protein Eng. Des. Sel. 24, 291-299. (doi:10.1093/protein/gzq105)
56. Bush RM, Fitch WM, Bender CA, Cox NJ. 1999 Positive selection on the H3 hemagglutinin gene of human influenza. Mol. Biol. Evol. 16, 1457-1465. (doi:10.1093/oxfordjournals.molbev.a026057)
57. Lee MS, Chen MC, Liao YC, Hsiung CA. 2007 Identifying potential immunodominant positions and predicting antigenic variants of influenza A/H3N2 viruses. Vaccine 25, 8133-8139. (doi:10.1016/j.vaccine.2007.09.039)
58. Arinaminpathy N, Grenfell B. 2010 Dynamics of glycoprotein charge in the evolutionary history of human influenza. PLoS ONE 5, e155674. (doi:10.1371/journal.pone.0015674)
59. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. 1982 The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31, 417-427. (doi:10.1016/0092-8674(82) 90135-0)
60. Kaverin NV, Rudneva IA, Govorkova EA, Timofeeva TA, Shilov AA, Kochergin-Nikitsky KS, Krylov PS, Webster RG. 2007 Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J. Virol. 81, 12 911-12 917. (doi:10.1128/JVI.01522-07)
61. Kryazhimskiy S, Dushoff J, Bazykin GA, Plotkin JB. 2011 Prevalence of epistasis in the evolution of influenza A surface proteins. PLoS Genet. 7, e1001301. (doi:10.1371/journal.pgen.1001301)
62. Kucharski A, Gog JR. 2012 Influenza emergence in the face of evolutionary constraints. Proc. Biol. Sci. 279, 645-652. (doi:10.1098/rspb.2011.1168)
63. Rudneva I et al. 2012 Escape mutants of pandemic influenza A/H1N1 2009 virus: variations in antigenic specificity and receptor affinity of the hemagglutinin. Virus Res. 166, 61-67. (doi:10.1016/j.virusres.2012.03.003)
64. Xu R, Ekiert DC, Krause JC, Hai R, Crowe Jr JE, Wilson IA. 2010 Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328, 357-360. (doi:10.1126/science.1186430)
65. Greenbaum JA et al. 2009 Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc. Natl Acad. Sci. USA 106, 20 365-20 370. (doi:10.1073/pnas.0911580106)
66. Khurana S et al. 2009 Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets. PLoS Med. 6, e1000049. (doi:10.1371/journal.pmed.1000049)
67. Stray SJ, Pittman LB. 2012 Subtype-and antigenic site-specific differences in biophysical influences on evolution of influenza virus hemagglutinin. Virol. J. 9, 91. (doi:10.1186/1743-422X-9-91)
68. Soundararajan V, Zheng S, Patel N, Warnock K, Raman R, Wilson IA, Raguram S, Sasisekharan V, Sasisekharan R. 2011 Networks link antigenic and receptor-binding sites of influenza hemagglutinin: mechanistic insight into fitter strain propagation. Sci. Rep. 1, 200. (doi:10.1038/srep00200)
69. Baigent SJ, McCauley JW. 2001 Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture. Virus Res. 79, 177-185. (doi:10.1016/S0168-1702(01) 00272-6)
70. Ndifon W, Wingreen NS, Levin SA. 2009 Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines. Proc. Natl Acad. Sci. USA 106, 8701-8706. (doi:10.1073/pnas.0903427106)
71. De Franco A, Locksley R, Robertson M. 2007 Immunity: The immune response in infectious and inflammatory disease. Oxford, UK: Oxford University Press.
72. Treanor J. 2004 Influenza vaccine-outmanoeuvring antigenic shift and drift. N. Engl. J. Med. 350, 218-220. (doi:10.1056/NEJMp038238)
73. Brammer TL, Izurieta HS, Fukuda K, Schmeltz LM, Regnery HL, Hall HE, Cox NJ. 2000 Surveillance for influenza-United States, 1994-95, 1995-96, and 1996-97 seasons. MMWR. CDC. Surveill. Summ. 49, 13-28.
74. Zinder D, Bedford T, Gupta S, Pascual M. 2013 The roles of competition and mutation in shaping antigenic and genetic diversity in influenza. PLoS Pathog. 9, e1003104. (doi:10.1371/journal.ppat.1003104)